TerminatedNCT05804708
Phase 2 Clinical Trial of GH001 in Postpartum Depression
Medication studyAges 18–45Netherlands + United Kingdom
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
- Listed locations
- Amsterdam and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 2, 2023
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 10
- Sponsor
- GH Research Ireland Limited
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom, Netherlands
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT05804708
- Official title
Show the full official title
A Phase 2 Clinical Trial of GH001 in Patients with Postpartum Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Amsterdam, Netherlands · London, United Kingdom · Sheffield, United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GH Research Ireland Limited.
Does this study involve medication?
Yes. The study involves medication, including GH001.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
